ALDVI
Sign in
Advicenne
Save
25.92M
Market cap
–
Current P/E
–
Forward P/E
About
Health care
Sector
Biotechnology
Industry
Advicenne S. A., a specialty pharmaceutical company, develops and commercializes treatments for nephrology. Its lead product candidate is Sibnayal for the treatment of distal renal tubular acidosis, as well as for the treatment of cystinuria.
Similar securities
Based on sector and market capitalization
Report issue